Page last updated: 2024-08-24

capecitabine and Vascular Diseases

capecitabine has been researched along with Vascular Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Endo, I; Ishibe, A; Momiyama, M; Nagamine, K; Ota, M; Saigusa, Y; Saito, S; Suwa, H; Suwa, Y; Suzuki, S; Watanabe, J; Watanabe, K; Yamanaka, T	1

Trials

1 trial(s) available for capecitabine and Vascular Diseases

Article	Year
Randomized phase II trial of the prophylactic use of celecoxib for the prevention of oxaliplatin-related peripheral vascular pain in Capeox (YCOG1205). Cancer chemotherapy and pharmacology, 2019, Volume: 83, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Celecoxib; Chemotherapy, Adjuvant; Colorectal Neoplasms; Cyclooxygenase 2 Inhibitors; Female; Humans; Male; Middle Aged; Oxaliplatin; Pain; Pain Measurement; Treatment Outcome; Vascular Diseases	2019

Article

Year

Randomized phase II trial of the prophylactic use of celecoxib for the prevention of oxaliplatin-related peripheral vascular pain in Capeox (YCOG1205).

Cancer chemotherapy and pharmacology, 2019, Volume: 83, Issue:3

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Celecoxib; Chemotherapy, Adjuvant; Colorectal Neoplasms; Cyclooxygenase 2 Inhibitors; Female; Humans; Male; Middle Aged; Oxaliplatin; Pain; Pain Measurement; Treatment Outcome; Vascular Diseases

2019